These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8969186)

  • 21. Apolipoprotein A-I-stimulated apolipoprotein E secretion from human macrophages is independent of cholesterol efflux.
    Kockx M; Rye KA; Gaus K; Quinn CM; Wright J; Sloane T; Sviridov D; Fu Y; Sullivan D; Burnett JR; Rust S; Assmann G; Anantharamaiah GM; Palgunachari MN; Katz SL; Phillips MC; Dean RT; Jessup W; Kritharides L
    J Biol Chem; 2004 Jun; 279(25):25966-77. PubMed ID: 15066991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-function studies of apoA-I variants: site-directed mutagenesis and natural mutations.
    Sviridov D; Hoang A; Huang W; Sasaki J
    J Lipid Res; 2002 Aug; 43(8):1283-92. PubMed ID: 12177172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of reconstituted high density lipoprotein discs containing human apolipoprotein A-I (ApoA-I) variants with murine adipocytes and macrophages. Evidence for reduced cholesterol efflux promotion by apoA-I(Pro165-->Arg).
    von Eckardstein A; Castro G; Wybranska I; Theret N; Duchateau P; Duverger N; Fruchart JC; Ailhaud G; Assmann G
    J Biol Chem; 1993 Feb; 268(4):2616-22. PubMed ID: 8428938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific phospholipid association with apolipoprotein A-I stimulates cholesterol efflux from human fibroblasts. Studies with reconstituted sonicated lipoproteins.
    Zhao Y; Sparks DL; Marcel YL
    J Biol Chem; 1996 Oct; 271(41):25145-51. PubMed ID: 8810270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel mutant, ApoA-I nichinan (Glu235-->0), is associated with low HDL cholesterol levels and decreased cholesterol efflux from cells.
    Han H; Sasaki J; Matsunaga A; Hakamata H; Huang W; Ageta M; Taguchi T; Koga T; Kugi M; Horiuchi S; Arakawa K
    Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1447-55. PubMed ID: 10364075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The C-terminal domain of apolipoprotein A-I is involved in ABCA1-driven phospholipid and cholesterol efflux.
    Favari E; Bernini F; Tarugi P; Franceschini G; Calabresi L
    Biochem Biophys Res Commun; 2002 Dec; 299(5):801-5. PubMed ID: 12470649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Removal of cellular cholesterol by pre-beta-HDL involves plasma membrane microsolubilization.
    Gillotte KL; Davidson WS; Lund-Katz S; Rothblat GH; Phillips MC
    J Lipid Res; 1998 Oct; 39(10):1918-28. PubMed ID: 9788238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux.
    Remaley AT; Schumacher UK; Stonik JA; Farsi BD; Nazih H; Brewer HB
    Arterioscler Thromb Vasc Biol; 1997 Sep; 17(9):1813-21. PubMed ID: 9327782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efflux of lipid from fibroblasts to apolipoproteins: dependence on elevated levels of cellular unesterified cholesterol.
    Bielicki JK; Johnson WJ; Weinberg RB; Glick JM; Rothblat GH
    J Lipid Res; 1992 Nov; 33(11):1699-709. PubMed ID: 1464753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formation of new HDL particles from lipid-free apolipoprotein A-I.
    Clay MA; Barter PJ
    J Lipid Res; 1996 Aug; 37(8):1722-32. PubMed ID: 8864956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of apolipoprotein structure on the efflux of cellular free cholesterol to high density lipoprotein.
    Davidson WS; Lund-Katz S; Johnson WJ; Anantharamaiah GM; Palgunachari MN; Segrest JP; Rothblat GH; Phillips MC
    J Biol Chem; 1994 Sep; 269(37):22975-82. PubMed ID: 8083197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The N-terminal globular domain and the first class A amphipathic helix of apolipoprotein A-I are important for lecithin:cholesterol acyltransferase activation and the maturation of high density lipoprotein in vivo.
    Scott BR; McManus DC; Franklin V; McKenzie AG; Neville T; Sparks DL; Marcel YL
    J Biol Chem; 2001 Dec; 276(52):48716-24. PubMed ID: 11602583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholesterol is poorly available for free apolipoprotein-mediated cellular lipid efflux from smooth muscle cells.
    Li Q; Komaba A; Yokoyama S
    Biochemistry; 1993 May; 32(17):4597-603. PubMed ID: 8485136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.
    Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
    Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deletion of amino acids Glu146-->Arg160 in human apolipoprotein A-I (ApoA-ISeattle) alters lecithin:cholesterol acyltransferase activity and recruitment of cell phospholipid.
    Lindholm EM; Bielicki JK; Curtiss LK; Rubin EM; Forte TM
    Biochemistry; 1998 Apr; 37(14):4863-8. PubMed ID: 9538003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trypsin-sensitive and lipid-containing sites of the macrophage extracellular matrix bind apolipoprotein A-I and participate in ABCA1-dependent cholesterol efflux.
    Burgess JW; Kiss RS; Zheng H; Zachariah S; Marcel YL
    J Biol Chem; 2002 Aug; 277(35):31318-26. PubMed ID: 12050168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein A-I configuration and cell cholesterol efflux activity of discoidal lipoproteins depend on the reconstitution process.
    Cuellar LÁ; Prieto ED; Cabaleiro LV; Garda HA
    Biochim Biophys Acta; 2014 Jan; 1841(1):180-9. PubMed ID: 24201377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural and functional basis for increased HDL-cholesterol levels due to the naturally occurring V19L mutation in human apolipoprotein A-I.
    Gkolfinopoulou C; Bourtsala A; Chroni A
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Mar; 1865(3):158593. PubMed ID: 31863971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of cholesterol efflux from Fu5AH hepatoma cells by the apolipoprotein content of high density lipoprotein particles. Particles containing various proportions of apolipoproteins A-I and A-II.
    Lagrost L; Dengremont C; Athias A; de Geitere C; Fruchart JC; Lallemant C; Gambert P; Castro G
    J Biol Chem; 1995 Jun; 270(22):13004-9. PubMed ID: 7768892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of ApoA-I structure on the ABCA1-mediated efflux of cellular lipids.
    Vedhachalam C; Liu L; Nickel M; Dhanasekaran P; Anantharamaiah GM; Lund-Katz S; Rothblat GH; Phillips MC
    J Biol Chem; 2004 Nov; 279(48):49931-9. PubMed ID: 15383537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.